-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
July 01, 2012 - Methods Guide for Medical Test Reviews Chapter 6
6-1
Chapter 6
Assessing Applicability of Medical Test Studies
in Systematic Reviews
Katherine E. Hartmann, M.D., Ph.D., Institute for Medicine and Public Health,
Vanderbilt University, Nashville, Tennessee
David B. Matchar, M.D., Center for Clinical Healt…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
August 11, 2014 - Many studies did not
adjust for age, history of coronary artery
disease, comorbidities, etc.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - Cardiac dysrhythmias and lipid disor-
ders—the latter being a surrogate for coronary artery dis-
ease—are
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
September 01, 2009 - In this 56-week trial of
100 participants of mostly European descent with
established carotid artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
October 25, 2011 - Project Name:
Source: www.effectivehealthcare.ahrq.gov
Published Online: October 25, 2011
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Comparative Effectiveness of Diagnosis and Treatment of
Obstructive Sleep Apnea in Adults
Draft revi…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
August 01, 2012 - CER # 23:
Effectiveness of Recombinant Human Growth Hormone (rhGH)
in the Treatment of Patients with Cystic Fibrosis
Original release date:
October 2010
Surveillance Report 1st Assessment: November, 2011
Surveillance Report 2nd Assessment: August 2012
Key Findings 1st Assessment:
• All conclusions for KQ…
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
August 27, 2012 - Congestive heart failure, hypertension, and
coronary artery disease fall under “heart
disease”. … Hypertension and
coronary artery disease are now grouped
under cardiovascular disease. … Hypertension and
coronary artery disease are now grouped
under cardiovascular disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual_130826.pdf
August 01, 2013 - added to a lead to denote subcategories within a broad priority
area (e.g., breast cancer, peripheral artery … Pancreas
03 Cardiovascular disease
Examples of subcategories: Aneurysms, Arrhythmias, Coronary Artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
December 01, 2014 - associated with mortality and comorbidities including type 2 diabetes mellitus (T2DM), coronary
artery … with comorbid obesity-related risk
factors or diseases (e.g., hypertension, dyslipidemia, coronary artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer_executive.pdf
October 01, 2014 - 1
Imaging Techniques for the Diagnosis and
Staging of Hepatocellular Carcinoma
Executive Summary
Background and Objectives
Hepatocellular carcinoma (HCC) is
the most common primary malignant
neoplasm of the liver, usually developing
in individuals with chronic liver disease
or cirrhosis. Worldwide, it is the f…
-
effectivehealthcare-admin.ahrq.gov/products/heart-failure-transition-care/research-protocol
December 01, 2019 - ultrafiltration, dialysis)
Technology aimed at guiding evaluation of patient volume status (e.g., pulmonary artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/undescended-testicle_executive.pdf
December 01, 2012 - The testicular blood supply then depends on
collateral circulation from the deferential artery and the
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
June 01, 2015 - increased risk of mortality and comorbidities, including type 2 diabetes mellitus
(T2DM), coronary artery … balloon, an intestinal barrier to reduce food
absorption, a procedure to embolize certain abdominal arteries
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-radiation_appendixes.pdf
June 16, 2008 - brain edema, cranial
nerve deficit, fat
necrosis,
hemiparesis, visual
loss, osteitis, basilar
artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
September 01, 2014 - is mentioned due to space considerations
Page 11: Revised to read “Atherosclerosis (hardening of arteries … by
plaque deposition) causes coronary heart disease (CHD), cerebrovascular
disease, and peripheral artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-protocol.pdf
December 01, 2011 - added to a
lead to denote subcategories within a broad priority area (e.g., breast cancer, peripheral artery … Pancreas
03 Cardiovascular disease
Examples of subcategories: Aneurysms, Arrhythmias, Coronary Artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-transition-care_research-protocol.pdf
June 10, 2013 - ultrafiltration, dialysis)
● Technology aimed at guiding evaluation
of patient volume status (e.g.,
pulmonary artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_executive.pdf
January 01, 2006 - • Two short-term trials in a high-risk post-
coronary-artery-surgery setting found that
valdecoxib
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-genetic_methods.pdf
July 01, 2012 - replication and a prospective meta-
analysis of the association between
chromosome 9p21.3 and coronary artery
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
May 01, 2013 - 1
Local Therapies for Unresectable Primary
Hepatocellular Carcinoma
Executive Summary
Introduction
Background
This comparative effectiveness review
evaluates local hepatic therapies for
patients with unresectable primary
hepatocellular carcinoma (HCC) who are
not candidates for surgical resection or
liver tr…